• DMG-PEG2000-NH2: Workflow & Optimization

  2026-09-28

  Use DMG-PEG2000-NH2 to add a primary-amine handle to PEG-containing lipid systems or conjugates, then optimize coupling and formulation as separate steps. This practical workflow pairs measurable linker and particle characterization with a cautious structure–activity lesson from an unrelated tuberculosis study.

• Lipo3K Transfection Reagent for Ferroptosis Studies

  2026-09-27

  See how Lipo3K Transfection Reagent can support causal experiments on OTUD3–SLC7A11 signaling and sunitinib resistance. This mechanism-first guide connects nucleic acid delivery choices with stronger ferroptosis assay interpretation.

• Orientia Modulates RIPK3 but Does Not Block Necroptosis

  2026-09-26

  This study finds that Orientia tsutsugamushi lowers cellular RIPK3 levels and does not trigger necroptosis in endothelial cells, but does not prevent RIPK3–MLKL signaling or cell death when the pathway is induced. The findings distinguish a change in pathway-component abundance from active blockade of necroptosis and provide a framework for testing how intracellular pathogens interact with host cell-death pathways.

• Z-WEHD-FMK for Interpreting Pyroptosis Assays

  2026-09-25

  Z-WEHD-FMK can help test whether inflammatory caspases contribute to a cell-death phenotype. This article connects its use to new HOXC8–CASP1 findings and explains how to distinguish caspase abundance, activity, and pathway dependence in assay design.

• DMG-PEG2000-NH2: A Design Logic for Assay Quality

  2026-09-25

  DMG-PEG2000-NH2 is an NH2-PEG derivative for building lipid-linked conjugates, but its value depends on more than successful coupling. This article connects its chemistry to a practical framework for measuring selectivity, formulation performance, and experimental limitations.

• Cy3 NHS ester (non-sulfonated): Labeling Guide

  2026-09-24

  Cy3 NHS ester (non-sulfonated) provides an orange fluorescent label for biomolecules with accessible primary amino groups when the labeling workflow can accommodate an organic co-solvent. It is not water-soluble, so it is a poor fit for aqueous-only protocols or solvent-sensitive samples unless compatibility is tested first.

• Gentamycin Sulfate for Resistance-Aware Assay Design

  2026-09-24

  Gentamycin Sulfate is an aminoglycoside antibiotic that can help researchers probe bacterial translation without treating one drug’s activity as a stand-in for another’s. This article connects ribosome-focused experiments with resistance-aware assay design and explains what a major European non-fermenter study can—and cannot—tell researchers.

• Sulfaphenazole-Derived Sulfonamides for Tuberculosis

  2026-09-23

  Chen and colleagues optimized sulfaphenazole-derived sulfonamides to retain antimycobacterial activity while reducing CYP 2C9 inhibition, a potential drug-interaction liability. Compound 10d showed the clearest balance in the reported in vitro data, although further studies are needed before the findings can be translated to treatment or clinical safety.

• Tapuy Lees Protect Neurons in C. elegans Models

  2026-09-23

  Remucal et al. show that Tapuy rice-wine lees and wine reduce amyloid-β toxicity and dopaminergic neurodegeneration in complementary C. elegans models. The study is notable for connecting a fermentation by-product with antioxidant activity, protein-aggregation phenotypes, neuronal preservation, and LC–MS/MS-based chemical profiling.

• RG7388: Translating Selective MDM2 Antagonism

  2026-09-22

  A translational oncology perspective on RG7388, linking selective MDM2 blockade and p53 pathway activation to biomarker strategy, combination studies, preclinical validation, and more disciplined experimental design.

• EZ Cap Cy5 Firefly Luciferase mRNA in Delivery Assays

  2026-09-22

  Discover how EZ Cap Cy5 Firefly Luciferase mRNA separates cellular uptake from productive translation through complementary Cy5 and luciferase readouts. This article connects reporter design with recent polymer-delivery research to improve assay interpretation, transfection optimization, and translational decision-making.

• Sulfaphenazole-Derived Sulfonamides for TB Selectivity

  2026-09-21

  Chen and colleagues optimized sulfaphenazole-derived sulfonamides to retain antimycobacterial activity while reducing CYP2C9 inhibition, identifying compound 10d as a particularly useful lead. The study provides a focused structure–activity relationship framework for combining antibacterial screening with an early drug–drug interaction counter-screen.

• Live-Dead Cell Staining Kit I for Hydrogel Assays

  2026-09-21

  Translate conductive-hydrogel design into actionable mammalian cell viability data with dual Calcein AM/PI fluorescence. This guide covers hydrogel extract testing, direct-contact workflows, imaging controls, and troubleshooting for reliable cytotoxicity interpretation.

• Syringin Natural Product in RCC Research

  2026-09-20

  Syringin is a phenylpropanoid glycoside used in natural product research and mechanistic renal cell carcinoma studies. Current evidence supports cell-based effects on viability, migration, apoptosis, and EGFR/PI3K/Akt signaling, but it does not establish clinical efficacy.

• BCA Protein Assay Kit for BPD Research

  2026-09-19

  Translate LXR–cholesterol findings in bronchopulmonary dysplasia into reproducible protein-normalization workflows for lung tissue and MLE12 cell lysates. This practical guide combines bicinchoninic acid protein quantification, assay optimization, and troubleshooting for western blotting, enzyme assays, and related molecular biology applications.

550 records 3/37 page Previous Next 12345 下5页 Last page